JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
2.17 HKD
0.46%
Updated:
May 31, 2024
JW (Cayman) Therapeutics Co Ltd
Accrued Liabilities
|
JW (Cayman) Therapeutics Co Ltd
Accrued Liabilities Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Accrued Liabilities
¥88.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Accrued Liabilities
¥2.6B
|
CAGR 3-Years
49%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Accrued Liabilities
¥2.2B
|
CAGR 3-Years
38%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Accrued Liabilities
¥268.5m
|
CAGR 3-Years
37%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Accrued Liabilities
¥1.3B
|
CAGR 3-Years
257%
|
CAGR 5-Years
152%
|
CAGR 10-Years
91%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Accrued Liabilities
¥82.7m
|
CAGR 3-Years
45%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Accrued Liabilities?
Accrued Liabilities
88.3m
CNY
88.3m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Accrued Liabilities amounts to 88.3m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
27%
27%
Over the last year, the Accrued Liabilities growth was 0%. The average annual Accrued Liabilities growth rates for JW (Cayman) Therapeutics Co Ltd have been 17% over the past three years , 27% over the past five years .
You don't have any saved screeners yet
